Literature DB >> 22639973

FFA1-selective agonistic activity based on docking simulation using FFA1 and GPR120 homology models.

Masato Takeuchi1, Akira Hirasawa, Takafumi Hara, Ikuo Kimura, Tatsuya Hirano, Takayoshi Suzuki, Naoki Miyata, Takeo Awaji, Masaji Ishiguro, Gozoh Tsujimoto.   

Abstract

BACKGROUND AND PURPOSE The free fatty acid FFA1 receptor and GPR120 are GPCRs whose endogenous ligands are medium- and long-chain FFAs, and they are important in regulating insulin and GLP-1 secretion respectively. Given that the ligands of FFA1 receptor and GPR120 have similar properties, selective pharmacological tools are required to study their functions further. EXPERIMENTAL APPROACH We used a docking simulation approach using homology models for each receptor. Biological activity was assessed by phosphorylation of ERK and elevation of intracellular calcium ([Ca(2+) ]i ) in cells transfected with FFA1 receptor or GPR120. Insulin secretion from murine pancreatic beta cells (MIN6) was also measured. KEY RESULTS Calculated hydrogen bonding energies between a series of synthetic carboxylic acid compounds and the homology models of the FFA1 receptor and GPR120, using docking simulations, correlated well with the effects of the compounds on ERK phosphorylation in transfected cells (R(2) = 0.65 for FFA1 receptor and 0.76 for GPR120). NCG75, the compound with the highest predicted selectivity for FFA1 receptors from this structure-activity relationship analysis, activated ERK and increased [Ca(2+) ]i as potently as the known FFA1 receptor-selective agonist, Compound 1. Site-directed mutagenesis analysis based on the docking simulation showed that different amino acid residues were important for the recognition and activation by FFA1 receptor agonists. Moreover, NCG75 strongly induced ERK and [Ca(2+) ]i responses, and promoted insulin secretion from MIN6 cells, which express endogenous FFA1 receptors. CONCLUSION AND IMPLICATIONS A docking simulation approach using FFA1 receptor and GPR120 homology models could be useful in predicting FFA1 receptor-selective agonists.
© 2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22639973      PMCID: PMC3605867          DOI: 10.1111/j.1476-5381.2012.02052.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

Review 1.  The ins and outs of fatty acids on the pancreatic beta cell.

Authors:  Vincent Poitout
Journal:  Trends Endocrinol Metab       Date:  2003-07       Impact factor: 12.015

2.  Reduction in voltage-gated K+ currents in primary cultured rat pancreatic beta-cells by linoleic acids.

Authors:  Dan Dan Feng; Ziqiang Luo; Sang-Gun Roh; Maria Hernandez; Neveen Tawadros; Damien J Keating; Chen Chen
Journal:  Endocrinology       Date:  2005-10-27       Impact factor: 4.736

Review 3.  G protein coupled receptor structure and activation.

Authors:  Brian K Kobilka
Journal:  Biochim Biophys Acta       Date:  2006-11-15

4.  Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules.

Authors:  Celia P Briscoe; Andrew J Peat; Stephen C McKeown; David F Corbett; Aaron S Goetz; Thomas R Littleton; David C McCoy; Terry P Kenakin; John L Andrews; Carina Ammala; James A Fornwald; Diane M Ignar; Stephen Jenkinson
Journal:  Br J Pharmacol       Date:  2006-05-15       Impact factor: 8.739

5.  MolDock: a new technique for high-accuracy molecular docking.

Authors:  René Thomsen; Mikael H Christensen
Journal:  J Med Chem       Date:  2006-06-01       Impact factor: 7.446

6.  Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120.

Authors:  Akira Hirasawa; Keiko Tsumaya; Takeo Awaji; Susumu Katsuma; Tetsuya Adachi; Masateru Yamada; Yukihiko Sugimoto; Shunichi Miyazaki; Gozoh Tsujimoto
Journal:  Nat Med       Date:  2004-12-26       Impact factor: 53.440

7.  Synthesis and activity of small molecule GPR40 agonists.

Authors:  Dulce M Garrido; David F Corbett; Kate A Dwornik; Aaron S Goetz; Thomas R Littleton; Steve C McKeown; Wendy Y Mills; Terrence L Smalley; Celia P Briscoe; Andrew J Peat
Journal:  Bioorg Med Chem Lett       Date:  2006-01-24       Impact factor: 2.823

8.  Molecular evolution of adrenoceptors and dopamine receptors: implications for the binding of catecholamines.

Authors:  Henri Xhaard; Ville-Veikko Rantanen; Tommi Nyrönen; Mark S Johnson
Journal:  J Med Chem       Date:  2006-03-09       Impact factor: 7.446

Review 9.  G protein-coupled receptors for free fatty acids.

Authors:  Graeme Milligan; Leigh A Stoddart; Andrew J Brown
Journal:  Cell Signal       Date:  2006-03-30       Impact factor: 4.315

10.  Bidirectional, iterative approach to the structural delineation of the functional "chemoprint" in GPR40 for agonist recognition.

Authors:  Irina G Tikhonova; Chi Shing Sum; Susanne Neumann; Craig J Thomas; Bruce M Raaka; Stefano Costanzi; Marvin C Gershengorn
Journal:  J Med Chem       Date:  2007-06-07       Impact factor: 7.446

View more
  4 in total

1.  Agonism of GPR120 prevented IL-1β-induced reduction of extracellular matrix through SOX-9.

Authors:  Zhixian Xu; Tie Ke; Yongfa Zhang; Chaofeng Fu; Wubing He
Journal:  Aging (Albany NY)       Date:  2020-06-24       Impact factor: 5.682

Review 2.  Free fatty acid receptors in the endocrine regulation of glucose metabolism: Insight from gastrointestinal-pancreatic-adipose interactions.

Authors:  Yu-Feng Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-28       Impact factor: 6.055

3.  A novel antidiabetic drug, fasiglifam/TAK-875, acts as an ago-allosteric modulator of FFAR1.

Authors:  Chiori Yabuki; Hidetoshi Komatsu; Yoshiyuki Tsujihata; Risa Maeda; Ryo Ito; Kae Matsuda-Nagasumi; Kensuke Sakuma; Kazumasa Miyawaki; Naoya Kikuchi; Koji Takeuchi; Yugo Habata; Masaaki Mori
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

Review 4.  Therapeutic role and ligands of medium- to long-chain Fatty Acid receptors.

Authors:  Takafumi Hara; Atsuhiko Ichimura; Akira Hirasawa
Journal:  Front Endocrinol (Lausanne)       Date:  2014-06-02       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.